Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods-Reference-Cited by-同舟云学术

Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods

Published:2024-06 Issue: Volume:192 Page:107818
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Shi Mengting,Pang Lanlan,Zhou Huaqiang,Mo Silang,Sheng Jin,Zhang Yaxiong,Liu Jiaqing,Sun Dongchen,Gong Longlong^ORCID,Wang Jiawei,Zhuang Weitao,Huang Yihua,Chen Zihong,Zhao Yuanyuan,Li Jing,Huang Yan,Yang Yunpeng,Fang Wenfeng,Zhang Li

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference23 articles.

1. SMARCA4: implications of an altered chromatin-remodeling gene for cancer development and therapy;Mardinian;Mol. Cancer Ther.,2021

2. The 2021 WHO classification of lung tumors: impact of advances since 2015;Nicholson;J. Thorac. Oncol.,2022

3. SMARCA4/BRG1-deficient non-small cell lung carcinomas: A case series and review of the literature;Nambirajan;Arch. Pathol. Lab. Med.,2021

4. SMARCA4 and other SWItch/sucrose nonfermentable family genomic alterations in NSCLC: clinicopathologic characteristics and outcomes to immune checkpoint inhibition;Alessi;J. Thorac. Oncol.,2021

5. Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden;Naito;Lung Cancer,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Intestine Metastasis Leads to the Diagnosis of Thoracic SMARCA4-Deficient Undifferentiated Tumor: A Case Report;Cureus;2024-09-01